Getein Hematology Analyzers
- Getein Biotech introduced cost-focused automated hematology analyzers aimed at routine lab work. - The devices offer 3-part and 5-part differential counts with 'no-residue' reagents, positioning them as low-cost options. - The launch targets clinical and smaller labs that need automated CBCs without heavy reagent waste, expanding procurement choices (x.com).
A complete blood count is one of medicine’s most common blood tests, and Getein Biotech is pushing new analyzers built to do that routine work at lower operating cost. (getein.com) (medlineplus.gov) A complete blood count measures red cells, white cells, platelets, hemoglobin, and related indices from a blood sample. Modern hematology analyzers automate that count so clinics and laboratories can process routine tests faster and with less manual handling. (medlineplus.gov) (ncbi.nlm.nih.gov) Getein’s current lineup includes the BHA-3000, a 3-part white blood cell differential system, and the BHA-5100, a 5-part differential system. The company says the BHA-3000 reports 21 parameters, uses 6 microliters of venous blood, and runs on two reagents: one diluent and one lyse solution. (getein.com 1) (getein.com 2) A 3-part differential groups white blood cells into three buckets, while a 5-part differential splits them into all five major types: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. That extra sorting can give clinicians more detail when they are checking for infection, inflammation, allergy, or blood disorders. (medlineplus.gov) (beckmancoulter.com) That division also maps to different lab budgets and workloads. Sysmex says 3-part analyzers are typically aimed at physician office laboratories, clinics, and small hospitals, while 5-part systems are used when labs want more diagnostic detail from the same core blood count workflow. (sysmex.com) (beckmancoulter.com) Getein is pitching its lower-end system on consumables as much as hardware. The BHA-3000 product page says its diluent and lysing reagents leave “no residue,” a claim tied to easier maintenance and lower reagent waste in routine use. (getein.com) The company is not a startup entering the field for the first time. Getein says it was established in 2002, is listed under stock code 603387, and sells in vitro diagnostic products across hematology, chemistry, coagulation, molecular diagnostics, and point-of-care testing. (getein.com) The immediate effect is a wider procurement menu for labs that do standard blood counts but cannot justify a larger, higher-throughput platform. In a market where major vendors already segment instruments by lab size, another low-footprint 3-part and 5-part option gives buyers one more way to trade off detail, maintenance, and reagent use. (mindray.com) (sysmex.com)
